© Rosalind Scientific LLC 2018-2022
© Rosalind Scientific LLC, 2018-2022
New Drug Hunter content, featured events and job postings straight to your inbox. Trusted by >3,500 drug hunters worldwide, unsubscribe anytime.
<< Back to August
oral, selective PKC_ kinase inhibitor
Ph. I candidate for Psoriasis
from screen of internal library and SBDD
Journal of Medicinal Chemistry
Celgene/BMS, San Diego, CA, USA
The Celgene/BMS PKCθ kinase inhibitor, CC-90005, highlighted by Julien Lefranc, is a clinical candidate in Ph. I for psoriasis, with some dosing being conducted in healthy volunteers. The safety profile is…
Ask your company or librarian about a Drug Hunter membership to to see all summaries and get access to even more helpful information.